Puma Biotechnology, Inc. (PBYI)
7.055
+0.20
(+2.99%)
USD |
NASDAQ |
Jun 09, 16:00
7.055
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology SG&A Expense (Quarterly) : 18.42M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 12.03M |
| AbbVie, Inc. | 3.578B |
| Agios Pharmaceuticals, Inc. | 48.30M |
| UroGen Pharma Ltd. | 51.49M |
| ACADIA Pharmaceuticals, Inc. | 171.02M |